Ocumetics Technology Corp. provided an update on the status of preclinical studies for its first product, the Bionic Lens. Since January 2022, Ocumetics has been busy undertaking a series of studies using cadaver donor eyes to determine how Ocumetics' optical technologies would fit in the human eye.

These studies have led to design enhancements to perfect how the Bionic Lens conforms to the lens capsular bag of the human eye. The studies, and resulting design enhancements, were supervised by Ocumetics' regulatory approval expert, Dr. Barbara Fant, Ocumetics' founder and Chief Scientific Officer, Dr. Garth Webb, and Chief Medical Officer, Dr. Doyle Stulting.